A citation-based method for searching scientific literature

N Avril, M Menzel, J Dose, M Schelling, W Weber, F Jänicke, W Nathrath, M Schwaiger. J Nucl Med 2001
Times Cited: 302







List of co-cited articles
588 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Andreas Buck, Holger Schirrmeister, Thorsten Kühn, Changxian Shen, Thomas Kalker, Jörg Kotzerke, Anja Dankerl, Gerhard Glatting, Sven Reske, Torsten Mattfeldt. Eur J Nucl Med Mol Imaging 2002
214
44

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.
Reinhard Bos, Jacobus J M van Der Hoeven, Elsken van Der Wall, Petra van Der Groep, Paul J van Diest, Emile F I Comans, Urvi Joshi, Gregg L Semenza, Otto S Hoekstra, Adriaan A Lammertsma,[...]. J Clin Oncol 2002
412
29

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.
David Groheux, Sylvie Giacchetti, Jean-Luc Moretti, Raphael Porcher, Marc Espié, Jacqueline Lehmann-Che, Anne de Roquancourt, Anne-Sophie Hamy, Caroline Cuvier, Laetitia Vercellino,[...]. Eur J Nucl Med Mol Imaging 2011
246
27

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.
N Avril, C A Rosé, M Schelling, J Dose, W Kuhn, S Bense, W Weber, S Ziegler, H Graeff, M Schwaiger. J Clin Oncol 2000
353
23

Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer.
Rakesh Kumar, Anil Chauhan, Hongming Zhuang, Prem Chandra, Mitchell Schnall, Abass Alavi. Breast Cancer Res Treat 2006
131
21

Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation.
F Crippa, E Seregni, R Agresti, C Chiesa, C Pascali, A Bogni, D Decise, V De Sanctis, M Greco, M G Daidone,[...]. Eur J Nucl Med 1998
136
20

Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Shigeto Ueda, Hitoshi Tsuda, Hideki Asakawa, Takashi Shigekawa, Kazuhiko Fukatsu, Nobuo Kondo, Mikio Yamamoto, Yukihiro Hama, Katsumi Tamura, Jiro Ishida,[...]. Jpn J Clin Oncol 2008
154
19


Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
A Gil-Rendo, F Martínez-Regueira, G Zornoza, M J García-Velloso, C Beorlegui, N Rodriguez-Spiteri. Br J Surg 2009
117
18

18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.
Joseph R Osborne, Elisa Port, Mithat Gonen, Ashley Doane, Henry Yeung, William Gerald, Josh B Cook, Steven Larson. J Nucl Med 2010
75
17

The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions.
Ayse Mavi, Tevfik F Cermik, Muammer Urhan, Halis Puskulcu, Sandip Basu, Jian Q Yu, Hongming Zhuang, Brian Czerniecki, Abass Alavi. J Nucl Med 2007
63
20

The relationship between FDG uptake in PET scans and biological behavior in breast cancer.
Wataru Shimoda, Mitsuhiro Hayashi, Koji Murakami, Tetsunari Oyama, Masakatsu Sunagawa. Breast Cancer 2007
71
15

Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors.
Naoki Ikenaga, Naoki Otomo, Atsushi Toyofuku, Yuji Ueda, Kiyokazu Toyoda, Tohru Hayashi, Kiyoshi Nishikawa, Masao Tanaka. Am Surg 2007
51
21

18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.
Hye Ryoung Koo, Jeong Seon Park, Keon Wook Kang, Nariya Cho, Jung Min Chang, Min Sun Bae, Won Hwa Kim, Su Hyun Lee, Mi Young Kim, Jin You Kim,[...]. Eur Radiol 2014
61
18


Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
David Fuster, Joan Duch, Pilar Paredes, Martín Velasco, Montserrat Muñoz, Gorane Santamaría, Montserrat Fontanillas, Francesca Pons. J Clin Oncol 2008
188
10

Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.
David Groheux, Elif Hindié, Marc Delord, Sylvie Giacchetti, Anne-sophie Hamy, Cédric de Bazelaire, Anne de Roquancourt, Laetitia Vercellino, Marie-Elisabeth Toubert, Pascal Merlet,[...]. J Natl Cancer Inst 2012
89
10

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
9

[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy.
Alina Berriolo-Riedinger, Claude Touzery, Jean-Marc Riedinger, Michel Toubeau, Bruno Coudert, Laurent Arnould, Christophe Boichot, Alexandre Cochet, Pierre Fumoleau, François Brunotte. Eur J Nucl Med Mol Imaging 2007
130
9

Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors.
Pierre Heudel, Sebastien Cimarelli, Anthony Montella, Catherine Bouteille, Thomas Mognetti. Int J Clin Oncol 2010
57
15

Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.
F Dehdashti, J E Mortimer, B A Siegel, L K Griffeth, T J Bonasera, M J Fusselman, D D Detert, P D Cutler, J A Katzenellenbogen, M J Welch. J Nucl Med 1995
250
9

Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.
Brittany Z Dashevsky, Debra A Goldman, Molly Parsons, Mithat Gönen, Adriana D Corben, Maxine S Jochelson, Clifford A Hudis, Monica Morrow, Gary A Ulaner. Eur J Nucl Med Mol Imaging 2015
43
20

Increased FDG uptake in breast cancer is associated with prognostic factors.
Yasemin Sanli, Serkan Kuyumcu, Zeynep Gozde Ozkan, Göknur Işik, Hasan Karanlik, Burcu Guzelbey, Cuneyt Turkmen, Sevda Ozel, Ekrem Yavuz, Ayse Mudun. Ann Nucl Med 2012
47
19


Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
8

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.
Richard L Wahl, Heather Jacene, Yvette Kasamon, Martin A Lodge. J Nucl Med 2009
8

Clinical significance of incidental finding of focal activity in the breast at 18F-FDG PET/CT.
Bong Joo Kang, Ji Hye Lee, Ie Ryung Yoo, Sung Hun Kim, Jae Jeong Choi, Seung Hee Jeong, Hyeon Woo Yim. AJR Am J Roentgenol 2011
40
20

Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
Masahiro Ohara, Hideo Shigematsu, Yasuhiro Tsutani, Akiko Emi, Norio Masumoto, Shinji Ozaki, Takayuki Kadoya, Morihito Okada. Breast 2013
35
22

Understanding the Warburg effect: the metabolic requirements of cell proliferation.
Matthew G Vander Heiden, Lewis C Cantley, Craig B Thompson. Science 2009
8

Performance of FDG PET/CT in the clinical management of breast cancer.
David Groheux, Marc Espié, Sylvie Giacchetti, Elif Hindié. Radiology 2013
145
7

Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
Wendie A Berg, Lorena Gutierrez, Moriel S NessAiver, W Bradford Carter, Mythreyi Bhargavan, Rebecca S Lewis, Olga B Ioffe. Radiology 2004
869
7

Prognostic Value of Primary Tumor Uptake on F-18 FDG PET/CT in Patients with Invasive Ductal Breast Cancer.
Bong-Il Song, Chae Moon Hong, Hong Je Lee, Sungmin Kang, Shin Young Jeong, Hae Won Kim, Yee Soo Chae, Ji Young Park, Sang-Woo Lee, Byeong-Cheol Ahn,[...]. Nucl Med Mol Imaging 2011
36
19

Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography.
Tomoo Inoue, Kenji Yutani, Tetsuya Taguchi, Yasuhiro Tamaki, Eiichi Shiba, Shinzaburo Noguchi. J Cancer Res Clin Oncol 2004
74
9

Biological characterisation of breast cancer by means of PET.
Andreas K Buck, Holger Schirrmeister, Torsten Mattfeldt, Sven N Reske. Eur J Nucl Med Mol Imaging 2004
66
10

Recommendations on the use of 18F-FDG PET in oncology.
James W Fletcher, Benjamin Djulbegovic, Heloisa P Soares, Barry A Siegel, Val J Lowe, Gary H Lyman, R Edward Coleman, Richard Wahl, John Christopher Paschold, Norbert Avril,[...]. J Nucl Med 2008
676
7

Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma.
Ozgul Ekmekcioglu, Anar Aliyev, Sabire Yilmaz, Esra Arslan, Rana Kaya, Pinar Kocael, Melih Engin Erkan, Metin Halac, Kerim Sonmezoglu. Nucl Med Commun 2013
27
25

Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Molly P Hogan, Debra A Goldman, Brittany Dashevsky, Christopher C Riedl, Mithat Gönen, Joseph R Osborne, Maxine Jochelson, Clifford Hudis, Monica Morrow, Gary A Ulaner. J Nucl Med 2015
38
18



Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.
Luca Gianni, Urania Dafni, Richard D Gelber, Evandro Azambuja, Susanne Muehlbauer, Aron Goldhirsch, Michael Untch, Ian Smith, José Baselga, Christian Jackisch,[...]. Lancet Oncol 2011
448
6

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy.
B B Koolen, M J T F D Vrancken Peeters, J Wesseling, E H Lips, W V Vogel, T S Aukema, E van Werkhoven, K G A Gilhuijs, S Rodenhuis, E J Th Rutgers,[...]. Eur J Nucl Med Mol Imaging 2012
64
9

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose.
M Oshida, K Uno, M Suzuki, T Nagashima, H Hashimoto, H Yagata, T Shishikura, K Imazeki, N Nakajima. Cancer 1998
178
6

Unexpected focal hypermetabolic activity in the breast: significance in patients undergoing 18F-FDG PET/CT.
Ronald L Korn, Anne M Yost, Christopher C May, Eric R Kovalsky, Katherine M Orth, Tiffany A Layton, Denise Drumm. AJR Am J Roentgenol 2006
26
23

Degree of tumor FDG uptake correlates with proliferation index in triple negative breast cancer.
Julia Tchou, Seema S Sonnad, Meredith R Bergey, Sandip Basu, John Tomaszewski, Abass Alavi, Mitchell Schnall. Mol Imaging Biol 2010
53
11


Molecular subtypes of breast cancer: metabolic correlation with ¹⁸F-FDG PET/CT.
Ana María García Vicente, Ángel Soriano Castrejón, Alberto León Martín, Ignacio Chacón López-Muñiz, Vicente Muñoz Madero, María del Mar Muñoz Sánchez, Azahara Palomar Muñoz, Ruth Espinosa Aunión, Ana González Ageitos. Eur J Nucl Med Mol Imaging 2013
43
13

False-positive lesions mimicking breast cancer on FDG PET and PET/CT.
Margaret Adejolu, Lei Huo, Eric Rohren, Lumarie Santiago, Wei T Yang. AJR Am J Roentgenol 2012
75
8

On the origin of cancer cells.
O WARBURG. Science 1956
6




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.